News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lectus Therapeutics Announces Strategic Investment From Takeda Research Investment To Advance Discovery Programmes For Next-Generation Ion Channel Drugs



10/19/2005 5:11:14 PM

Lectus Therapeutics Limited (Lectus; www.lectustherapeutics.com), an emerging UK-based bio-pharmaceutical company focused on the discovery and development of next-generation ion channel modulators, announced today it had secured a strategic investment from Takeda Research Investment Inc. (TRI) to advance its core ion channel drug discovery and development programmes. Full details of the terms of the strategic partnership between Lectus and TRI were not disclosed.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES